InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by HENWOOD GERALDINE, Chief Executive Officer. Director active across 1 companies, notably Baudax Bio, Inc.. Aggregated, 9 filings have been published. Total volume traded: €16k. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
039,473 shares0
Common Stock
SEC:0001062993-22-015123:0·
€5,13018,636 shares@ €0.275331.7% of flow
Common Stock
SEC:0000899243-21-049629·
€5,13018,636 shares@ €0.275315.8% of flow
Common Stock
SEC:0000899243-21-049629:0·
€2,8349,155 shares@ €0.309617.5% of flow
Common Stock
SEC:0000899243-21-048181·
€2,8349,155 shares@ €0.30968.7% of flow
Common Stock
SEC:0000899243-21-048181:0·
€4,1058,200 shares@ €0.500625.3% of flow
Common Stock
SEC:0001192482-21-000728·
Ideal exit: 19 Jun 2022 (T+270)
€4,1058,200 shares@ €0.500612.7% of flow
Common Stock
SEC:0001192482-21-000728:0·
Ideal exit: 19 Jun 2022 (T+270)
€4,1366,000 shares@ €0.689425.5% of flow
Common Stock
SEC:0001192482-21-000407·
Ideal exit: 1 Feb 2022 (T+270)
€4,1366,000 shares@ €0.689412.8% of flow
Common Stock
SEC:0001192482-21-000407:0·
Ideal exit: 1 Feb 2022 (T+270)
9 of 9 declarations
About HENWOOD GERALDINE
HENWOOD GERALDINE serves as President and CEO at Baudax Bio, Inc. She is responsible for the strategic direction of the company and the management of its daily operations. Under her leadership, Baudax Bio is committed to developing innovative treatments for patients. HENWOOD GERALDINE plays a crucial role in defining the company's vision and establishing strong relationships with investors and partners.
